Exchange: Other OTC Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
0.00% $0.0001
/ 23 apr 2024 @ 13:38
FUNDAMENTALS | |
---|---|
MarketCap: | 0.0018 mill |
EPS: | -0.0100 |
P/E: | -0.0100 |
Earnings Date: | May 29, 2024 |
SharesOutstanding: | 17.68 mill |
Avg Daily Volume: | 0.0017 mill |
RATING 2024-04-23 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Neutral | |
Return On Asset: | Buy | |
DE: | Sell | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | n/a | n/a | |||
Gr.Profit | n/a | n/a | n/a | |||
Ebit | n/a | n/a | n/a | |||
Asset | n/a | n/a | n/a | |||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.0100 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -0.0100 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.0001 - 0.0001 ( +/- 0.00%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-08-08 | Wang Bernard | Sell | 131 887 | Stock Options |
2022-08-05 | Rose Benjamin | Buy | 0 | |
2022-06-07 | Megale Thomas J | Buy | 0 | |
2021-12-22 | Stegner Jeffrey | Buy | 0 | |
2022-02-18 | Megale Thomas J | Buy | 22 480 | Greenrose Holding Company Inc Common Stock |
INSIDER POWER |
---|
-100.00 |
Last 13 transactions |
Buy: 2 708 586 | Sell: 3 631 887 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $0.0001 (0.00% ) |
Volume | 0.0000 mill |
Avg. Vol. | 0.0017 mill |
% of Avg. Vol | 0.601 % |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.